MCK vs NXL · P/E 20, rev $403.43B vs rev $301.6K
McKesson Corporation (MCK) versus Nexalin Technology Inc. (NXL) — a side-by-side from cached financials, not a winner call.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
Nexalin Technology Inc. (NXL) is a medical devices company listed on NASDAQ.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Latest reported NXL revenue for 2025-12-31 was $301.6K. Net income was -$8.2M. Revenue was up 78.8% from 2024-12-31 to 2025-12-31. NXL currently screens at market cap $8.5M.
MCK currently screens at market cap $91.30B and trailing P/E 20.3. NXL currently screens at market cap $8.5M.
Not investment advice. Open the MCK and NXL stock pages for the full models.
Not investment advice.